Skip to content

Influence of Pretransplantation Myocardial and liver MRI in beta-thalassemia major undergoing Allogeneic Hematopoietic Stem Cell

Influence of Pretransplantation Myocardial and liver MRI in beta-thalassemia major undergoing Allogeneic Hematopoietic Stem Cell

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-17012573
Enrollment
Unknown
Registered
2017-09-05
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

beta-thalassemia major

Interventions

Gold Standard:A normal MRI T2* liver is >6.3 ms. Mild liver iron overload was defined by MRI T2* between 2.7 ms and 6.3 ms. Moderate liver iron overload was defined by MRI T2* between 1.4 ms and 2.7 m
Index test:Nuclear&#32
Magnetic&#32

Sponsors

First Affilited Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 14 Years

Inclusion criteria

Inclusion criteria: Patients are diagnosed ß-thalassaemia major and will proceed allogeneic hematopoietic stem cell transplantation. All cases are in line with HLA matching high-resolution 10/10 matched, age from 2 to14 years old. Gender is not limited to a male/female.

Exclusion criteria

Exclusion criteria: 1. Patients with unstable vital sign or by other physiological or mental reasons can not undergo MRI exam; 2. Relatives of the patient refuse to join this research; 3. Patients with other diseases which can lead to iron overload; 4. Patients with other diseases in liver or heart(ie. neoplasms); 5. patients have inflamation, liver disease, heart failure or arrhythmia.

Design outcomes

Primary

MeasureTime frame
serum ferritin (SF);iron level of liver;iron level of Myocardium;ejection fraction;

Countries

China

Contacts

Public ContactJianming Luo

Department of Pediatrics, The First Affiliated Hospital of Guangxi medical university

jmluo@aliyun.com+86 13517667021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026